Dale E. Hammerschmidt

4.8k total citations · 1 hit paper
102 papers, 3.0k citations indexed

About

Dale E. Hammerschmidt is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Hematology. According to data from OpenAlex, Dale E. Hammerschmidt has authored 102 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 16 papers in Immunology and 12 papers in Hematology. Recurrent topics in Dale E. Hammerschmidt's work include Complement system in diseases (10 papers), Ethics in Clinical Research (9 papers) and Health and Medical Research Impacts (7 papers). Dale E. Hammerschmidt is often cited by papers focused on Complement system in diseases (10 papers), Ethics in Clinical Research (9 papers) and Health and Medical Research Impacts (7 papers). Dale E. Hammerschmidt collaborates with scholars based in United States, Austria and Ghana. Dale E. Hammerschmidt's co-authors include Harry S. Jacob, Philip R. Craddock, Charles F. Moldow, Gregory M. Vercellotti, Howard L. Bleich, Mary Jean Moore, Christine Grady, Carol Levine, Jeremy Sugarman and Lisa Eckenwiler and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Dale E. Hammerschmidt

96 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement-Induced Granulocyte Aggregation

1980 390 citations Harry S. Jacob, Philip R. Craddock et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dale E. Hammerschmidt United States	26	583	556	394	374	372	102	3.0k
Carlos Pineda Mexico	35	1.2k 2.1×	396 0.7×	349 0.9×	335 0.9×	352 0.9×	181	4.1k
Bruce R. Lindgren United States	38	845 1.4×	368 0.7×	983 2.5×	556 1.5×	575 1.5×	180	4.9k
Mary A. De Vera Canada	35	869 1.5×	380 0.7×	355 0.9×	426 1.1×	423 1.1×	160	3.9k
L. Brandt Sweden	36	336 0.6×	301 0.5×	537 1.4×	663 1.8×	290 0.8×	156	4.3k
Ronald D. Guttmann Canada	33	1.2k 2.1×	717 1.3×	318 0.8×	282 0.8×	432 1.2×	125	3.8k
Kim Hørslev‐Petersen Denmark	39	538 0.9×	735 1.3×	223 0.6×	164 0.4×	386 1.0×	194	4.6k
Michal Yaron Israel	31	461 0.8×	454 0.8×	257 0.7×	398 1.1×	256 0.7×	163	2.9k
Geoff McColl Australia	26	408 0.7×	339 0.6×	145 0.4×	470 1.3×	180 0.5×	81	2.6k
Matthias Siebeck Germany	26	666 1.1×	288 0.5×	274 0.7×	286 0.8×	201 0.5×	148	2.4k
Rolf F. Maier Germany	29	362 0.6×	423 0.8×	1.1k 2.8×	332 0.9×	438 1.2×	127	3.2k

Countries citing papers authored by Dale E. Hammerschmidt

Since Specialization

Citations

This map shows the geographic impact of Dale E. Hammerschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale E. Hammerschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale E. Hammerschmidt more than expected).

Fields of papers citing papers by Dale E. Hammerschmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale E. Hammerschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale E. Hammerschmidt. The network helps show where Dale E. Hammerschmidt may publish in the future.

Co-authorship network of co-authors of Dale E. Hammerschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Dale E. Hammerschmidt. A scholar is included among the top collaborators of Dale E. Hammerschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale E. Hammerschmidt. Dale E. Hammerschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ivanovich, Peter, Dennis E. Chenoweth, Reinhard Schmidt, et al.. (2015). Cellulose Acetate Hemodialysis Membranes Are Better Tolerated than Cuprophan. Contributions to nephrology. 37. 78–82.

Hammerschmidt, Dale E.. (2008). Bias in the design, interpretation, and publication of industry-sponsored clinical research.. PubMed. 91(6). 46–7. 2 indexed citations

Cunningham, John M., Mrinal M. Patnaik, Dale E. Hammerschmidt, & Gregory M. Vercellotti. (2008). Historical perspective and clinical implications of the Pelger‐Huet cell. American Journal of Hematology. 84(2). 116–119. 28 indexed citations

Banton, Kaysie L., Jonathan D’Cunha, Noel Laudi, et al.. (2005). Postoperative Severe Microangiopathic Hemolytic Anemia Associated With a Giant Hepatic Cavernous Hemangioma. Journal of Gastrointestinal Surgery. 9(5). 679–685. 1 indexed citations

Hammerschmidt, Dale E.. (2004). Recruiting for a clinical study (disparities in health care and research). Journal of Laboratory and Clinical Medicine. 144(3). 167–168.

Levine, Carol, Ruth Faden, Christine Grady, et al.. (2004). The Limitations of “Vulnerability” as a Protection for Human Research Participants. The American Journal of Bioethics. 4(3). 44–49. 257 indexed citations

Woodward, Beverly & Dale E. Hammerschmidt. (2003). Requiring Consent vs. Waiving Consent for Medical Records Research: A Minnesota Law vs. the U.S. (HIPAA) Privacy Rule. Health Care Analysis. 11(3). 207–218. 4 indexed citations

Coad, James E., et al.. (2002). Cholecystitis as the presenting manifestation of acute myeloid leukemia. American Journal of Hematology. 70(3). 254–256. 9 indexed citations

Molinaro, Giuseppe A., et al.. (2002). Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des‐Arg⁹‐bradykinin after contact activation. Transfusion. 42(11). 1458–1465. 19 indexed citations

10.

Gupta, Pankaj, et al.. (1995). Pancytopenia due to hemophagocytic syndrome as the presenting manifestation of babesiosis. American Journal of Hematology. 50(1). 60–62. 33 indexed citations

11.

Hammerschmidt, Dale E., et al.. (1994). Anthracycline‐based therapy of de novo acute myeloid leukemia in adults: Failure of first‐cyde cytoreduction to predict second‐cycle outcome. American Journal of Hematology. 47(3). 172–177. 2 indexed citations

12.

Redl, Heinz, et al.. (1989). Inhibition by halothane, but not by isoflurane, of oxidative response to opsonized zymosan in whole blood. Inflammation. 13(6). 621–630. 10 indexed citations

13.

Redl, Heinz, et al.. (1989). Permeability studies in a hypovolemic traumatic shock model: Comparison of ringer's lactate and albumin as volume replacement fluids. Resuscitation. 17(1). 77–90. 4 indexed citations

14.

Hammerschmidt, Dale E., et al.. (1988). Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.. PubMed. 112(2). 254–63. 86 indexed citations

15.

Hammerschmidt, Dale E. & Gregory M. Vercellotti. (1988). Limitation of Complement Activation by Perfluorocarbon Emulsions:Superiority of Lecithin-Emulsified Preparations. Biomaterials Artificial Cells and Artificial Organs. 16(1-3). 431–438. 18 indexed citations

16.

Lamche, Herbert R., et al.. (1988). Development of a simple radioimmunoassay for human C3a. Inflammation. 12(3). 265–276. 1 indexed citations

17.

Hammerschmidt, Dale E., et al.. (1988). Inhibition of granulocyte function by steroids is not limited to corticoids. Inflammation. 12(3). 277–284. 19 indexed citations

18.

Hammerschmidt, Dale E.. (1987). The control of warfarin anticoagulation. A University of Minnesota medical conference.. PubMed. 70(10). 585–8. 1 indexed citations

19.

Swan, James W., et al.. (1983). Complement Activation by Trichophyton rubrum. Journal of Investigative Dermatology. 80(3). 156–158. 34 indexed citations

20.

Hammerschmidt, Dale E., David F. Stroncek, Timothy K. Bowers, et al.. (1981). Complement activation and neutropenia occurring during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 81(3). 370–377. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact